ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy
2018 · Oncogenesis · 54 citations
https://doi.org/10.1038/s41389-018-0096-9
C
Cynthia Waasdorp
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
73
Papers
914
Citations
13
h-index
18
i10-index
Cynthia Waasdorp is an academic researcher from Dutch Cancer Society. The author has contributed to research in topics: Immunotherapy and Immune Responses & Monoclonal and Polyclonal Antibodies Research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 13, co-authored 63 publications.
ORCID: 0009-0000-9162-7367Papers by this author
worksPhosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma
2023 · Cell Reports · 25 citations
https://doi.org/10.1016/j.celrep.2023.112581
Patched-2 functions to limit Patched-1 deficient skin cancer growth
2018 · Cellular Oncology · 16 citations
https://doi.org/10.1007/s13402-018-0381-9
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma
2024 · Communications Medicine · 2 citations
https://doi.org/10.1038/s43856-024-00512-z
Figure S7 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2024 · 0 citations
https://doi.org/10.1158/2326-6066.25964331.v1
Figure S16 from The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy
2024 · 0 citations
https://doi.org/10.1158/2326-6066.25964352.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat